Prognostic impact of KRAS mutation subtypes in 677 patients with metastatic lung adenocarcinomas

BACKGROUND: We previously demonstrated that patients with metastatic KRAS mutant lung cancers have a shorter survival compared to patients with KRAS wild type cancers. Recent reports have suggested different clinical outcomes and distinct activated signaling pathways depending on KRAS mutation subty...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Thorac Oncol
Autors principals: Yu, Helena A., Sima, Camelia S., Shen, Ronglai, Kass, Samantha, Gainor, Justin, Shaw, Alice, Hames, Megan, Iams, Wade, Aston, Jonathan, Lovly, Christine M., Horn, Leora, Lydon, Christine, Oxnard, Geoffrey R., Kris, Mark G., Ladanyi, Marc, Riely, Gregory J.
Format: Artigo
Idioma:Inglês
Publicat: 2015
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4479120/
https://ncbi.nlm.nih.gov/pubmed/25415430
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/JTO.0000000000000432
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars